The Ras superfamily of GTPases act as important regulatory switches to co-o
rdinate extracellular stimuli with activation of intracellular signaling pa
thways and appropriate biological responses. The Ras branch of this superfa
mily includes H-, K- and N-Ras, which are commonly mutated in particular hu
man cancers, but notably not in those of the breast. Instead, in breast can
cer the signaling pathways involving these GTPases may be upregulated due t
o increased coupling to growth factor receptors or other tyrosine kinases c
ommonly overexpressed in this disease, or increased expression of regulator
s, the Ras protein itself, or downstream effecters. Functional studies util
izing both in vitro and in vivo models demonstrate that Ras signaling can r
egulate a variety of endpoints relevant to breast cancer progression, inclu
ding anchorage dependent and independent growth, tumorigenesis, steroid sen
sitivity and invasion. Finally, analysis of the processing and signaling me
chanisms of the Ras superfamily has identified potential targets for therap
eutic intervention.